Abiomed (NASDAQ:ABMD) reported its Q4 earnings results on Thursday, April 28, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Abiomed beat estimated earnings by 6.42%, reporting an EPS of $1.16 versus an estimate of $1.09.
Revenue was up $28.60 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 1.77% increase in the share price the next day.
Here's a look at Abiomed's past performance:
| Quarter | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.97 | 0.97 | 1.05 | 1.10 |
| EPS Actual | 1.13 | 1.03 | 1.10 | 1.24 |
| Revenue Estimate | 252.84M | 247.66M | 240.91M | 230.38M |
| Revenue Actual | 261.18M | 248.14M | 252.59M | 241.25M |
To track all earnings releases for Abiomed visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
